ChEMBL ID: CHEMBL1743040
Mechanism of action: HLA-DR antigens-associated invariant chain antagonist
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Trials and conditions connected to MILATUZUMAB